$93.18 (2.22%)

Volume: 215.397k

Closed: Jan 27, 2023

Hollow Logo Score: -1.933
Amedisys Inc Stock
$93.18 (2.22%)

Volume: 215.397k

Closed: Jan 27, 2023

Score Hollow Logo -1.933

Amedisys Inc Stock Forecast

Updated Fri, Jan 27, 2023
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Be the first to comment on AMED

Green day on Friday for Amedisys Inc stock after gaining 2.22%
(Updated on Jan 27, 2023)

Sell candidate since 2023-01-26 Gain 2.22% PDF

The Amedisys Inc stock price gained 2.22% on the last trading day (Friday, 27th Jan 2023), rising from $91.16 to $93.18. During the last trading day the stock fluctuated 4.21% from a day low at $89.62 to a day high of $93.39. The price has risen in 8 of the last 10 days and is up by 11.46% over the past 2 weeks. Volume fell on the last day by -243 shares and in total, 215 thousand shares were bought and sold for approximately $20.07 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Give Options Surge a try today. And start trading with the pros, instead of behind them.* >>

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $95.67 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -2.93% during the next 3 months and, with a 90% probability hold a price between $76.62 and $92.87 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

AMED Signals & Forecast

The Amedisys Inc stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $93.31. On a fall, the stock will find some support from the long-term average at approximately $85.88. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, January 23, 2023, and so far it has fallen -2.80%. Further fall is indicated until a new bottom pivot has been found.

Here's how to open broker account if you're new to investing.

Support, Risk & Stop-loss for Amedisys Inc stock

Amedisys Inc finds support from accumulated volume at $92.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.77 between high and low, or 4.21%. For the last week, the stock has had daily average volatility of 4.21%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AMED) For The Upcoming Trading Day Of Monday 30th

For the upcoming trading day on Monday, 30th we expect Amedisys Inc to open at $92.06, and during the day (based on 14 day Average True Range), to move between $89.51 and $96.85, which gives a possible trading interval of +/-$3.67 (+/-3.94%) up or down from last closing price. If Amedisys Inc takes out the full calculated possible swing range there will be an estimated 7.88% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $92.50 (0.73%) than the resistance at $93.89 (0.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Amedisys Inc stock A Buy?

Amedisys Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.933 Open Broker Account

Sell Candidate Unchanged

Predicted Opening Price for Amedisys Inc of Monday, January 30, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price January 30, 2023 Current price
$92.06 $93.18 (Overvalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 95.83 2.85 %
R2 94.39 1.30 %
R1 93.50 0.347 %
Current price: 93.18
Support S1 90.62 -2.74 %
S2 89.73 -3.70 %
S3 88.29 -5.24 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 97.63 4.78 %
R2 95.12 2.08 %
R1 93.89 0.762 %
Current price 93.18
Support S1 92.50 -0.730%
S2 84.66 -9.14%
S3 81.49 -12.55%

Click to get the best stock tips daily for free!

Hot Stocks To Watch:

About Amedisys Inc

Amedisys Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitatio... AMED Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE